Reclassification of the specialized metabolite producer pseudomonas mesoacidophila ATCC 31433 as a member of the burkholderia cepacia complex by Loveridge, Edric Joel et al.
 1 
Reclassification of the specialized metabolite producer Pseudomonas mesoacidophila 1 
ATCC 31433 as a member of the Burkholderia cepacia complex 2 
 3 
E. Joel Loveridge,
a,b,
* Cerith Jones,
c
 Matthew J. Bull,
c
 Suzy C. Moody,
d
 Małgorzata W. 4 
Kahl,
b
 Zainab Khan,
b
 Louis Neilson,
a,e
 Marina Tomeva,
a,e
 Sarah E. Adams,
b,† 
 Andrew C. 5 
Wood,
b
 Daniel Rodriguez-Martin,
b,‡
 Ingrid Pinel,
b,§
 Julian Parkhill,
f
 Eshwar 6 
Mahenthiralingam
c,
* and John Crosby
g,
* 7 
 8 
a. Department of Chemistry, Swansea University, Singleton Park, Swansea SA2 8PP, UK 9 
b. School of Chemistry, Cardiff University, Park Place, Cardiff CF10 3AT, UK 10 
c. School of Biosciences, Cardiff University, Park Place, Cardiff CF10 3AT, UK 11 
d. Department of Biosciences, Swansea University, Singleton Park, Swansea SA2 8PP, 12 
UK 13 
e. School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, UK 14 
f. Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, 15 
Cambridge CB10 1SA, UK 16 
g. School of Chemistry, University of Bristol, Cantocks Close, Bristol BS8 1TS, UK 17 
 18 
Running title: Genome of P. mesoacidophila ATCC 31433 19 
 20 
Keywords: Genome, identification, antibiotic resistance, metal resistance, antibacterial, 21 
biosynthesis, bulgecin 22 
 23 
 2 
* Address correspondence to Joel Loveridge, Department of Chemistry, Swansea 1 
University, Singleton Park, Swansea SA2 8PP, UK, Tel: +44 (0)1792 513199, Email: 2 
e.j.loveridge@swansea.ac.uk; Eshwar Mahenthiralingam, School of Biosciences, Cardiff 3 
University, Park Place, Cardiff CF10 3AT, UK, Tel: +44 (0)29 20875875, Email: 4 
mahenthiralingame@cardiff.ac.uk; or John Crosby, School of Chemistry, University of 5 
Bristol, Cantocks Close, Bristol BS8 1TS, UK, Tel: +44 (0)117 9288445, Email: 6 
john.crosby@bristol.ac.uk. 7 
 8 
† Present address: The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK 9 
 10 
‡ Present address: Centro de Investigación en Sanidad Animal (CISA-INIA), 11 
Valdeolmos, Madrid 28130, Spain 12 
 13 
§ Present address: Faculty of Applied Sciences, Delft University, Van der Maasweg, 14 
2629 HZ Delft, Netherlands 15 
 16 
17 
 3 
ABSTRACT 1 
Pseudomonas mesoacidophila ATCC 31433 is a Gram-negative bacterium, first isolated 2 
from Japanese soil samples, which produces the monobactam isosulfazecin and the β-3 
lactam potentiating bulgecins. To characterize the biosynthetic potential of P. 4 
mesoacidophila ATCC 31433 its complete genome was determined using single 5 
molecule real time DNA sequence analysis. The 7.8 Mb genome comprised four 6 
replicons: three chromosomal, each encoding ribosomal RNA, and one plasmid. 7 
Phylogenetic analysis demonstrated that P. mesoacidopila ATCC 31433 was mis-8 
classified at the time of its deposition and is a member of the Burkholderia cepacia 9 
complex, most closely related to B. ubonensis. The sequenced genome shows 10 
considerable additional biosynthetic potential, with known gene clusters for 11 
malleilactone, ornibactin, isosulfazecin, alkylhydroxyquinoline and pyrrolnitrin 12 
biosynthesis, and several uncharacterized biosynthetic gene clusters for PKS, NRPS and 13 
other metabolites, identified. Furthermore P. mesoacidophila ATCC 31433 harbours 14 
many genes associated with environmental resilience and antibiotic resistance, and was 15 
resistant to a range of antibiotics and metal ions. In summary, this bioactive strain should 16 
be designated B. cepacia complex strain ATCC 31433 pending further detailed 17 
taxonomic characterization. 18 
 19 
IMPORTANCE 20 
This work reports the complete genome sequence of Pseudomonas mesoacidophila 21 
ATCC 31433, a known producer of bioactive compounds. A large number of both known 22 
and novel biosynthetic gene clusters were identified, indicating that P. mesoacidophila 23 
 4 
ATCC 31433 is an untapped resource for discovery of novel bioactive compounds. 1 
Phylogenetic analysis demonstrated that P. mesoacidopila ATCC 31433 is in fact a 2 
member of the Burkholderia cepacia complex, most closely related to the species B. 3 
ubonensis. Further investigation of the classification and biosynthetic potential of P. 4 
mesoacidopila ATCC 31433 is warranted. 5 
 6 
INTRODUCTION 7 
Pseudomonas mesacidophila was isolated from Japanese soil samples in the late 1970s 8 
(1). It is known to produce the sulfamate monobactam isosulfazecin (1) and the bulgecins 9 
(2), a group of sulfated glycopeptides that inhibit lytic transglycosylases (3) as well as 10 
metallo-β-lactamases (4), and which potentiate β-lactam activity (2, 5). Pseudomonas and 11 
other soil Gram-negative bacterial genera such as Stenotrophomonas and Burkholderia 12 
often show high levels of resistance to antibiotics (6). For example, Pseudomonas 13 
aeruginosa is a common nosocomial pathogen with a reduced susceptibility to a range of 14 
antibiotics due to the combined effect of its low membrane permeability, chromosomal 15 
multidrug efflux pumps and overexpressed β-lactamases, and the acquisition of multi-16 
drug resistance plasmids (6, 7). Stenotrophomonas maltophila is an emerging nosocomial 17 
pathogen (8), and several Burkholderia species, even environmental isolates, are resistant 18 
to a wide range of antibiotic classes (9). Species of both Pseudomonas and Burkholderia 19 
produce an array of bioactive specialized metabolites (10, 11). Despite this, the full 20 
biosynthetic potential and the antibiotic susceptibility of P. mesacidophila have not been 21 
reported. Here, we report the complete genome sequence of P. mesacidophila, and show 22 
that this species shares an antimicrobial-resistant phenotype characteristic of 23 
 5 
Burkholderia, and phylogenetically should be reclassified as a member of the B. cepacia 1 
complex. 2 
 3 
RESULTS 4 
Genome sequencing and taxonomic placement of P. mesoacidophila ATCC 31433 5 
within the Burkholderia genus. Previous studies show P. mesoacidophila ATCC 31433 6 
to be a producer of bioactive specialized metabolites (1, 2, 12). There is only one known 7 
example of this species, with no nucleotide sequences reported. Amplification and 8 
sequencing of 16s, recA and gyrB genes indicated that these sequences were closely 9 
related to Burkholderia species (data not shown) (13). To characterise this isolate, we 10 
obtained a complete genome using PacBio technology. The sequence assembled into four 11 
contigs, with a total size of 7.84 MB.  The sequences of six MLST loci from the genome 12 
were compared to characterised Burkholderia species. P. mesoacidophila ATCC 31433 13 
clusters most closely to Burkholderia ubonensis within the Burkholderia cepacia 14 
complex (Figure 1), confirming its misclassification. 15 
The genome sequence of P. mesoacidophila ATCC 31433 was compared to those of B. 16 
ubonensis, MSMB1471 (Accessions NZ_CP013462, NZ_CP013463, NZ_CP013464 and 17 
NZ_CP013465; Figure 2). Both genomes were organised similarly in three chromosomes, 18 
each encoding ribosomal RNA, and were largely syntenic. The B. ubonensis MSMB1471 19 
and P. mesoacidophila ATCC 31433 genomes shared an Average Nucleotide Identity 20 
(ANI) of 94.7%, which falls below the proposed species-level cut-off of 95% (14). These 21 
data suggest that P. mesoacidophila ATCC 31433, while clearly a member of the B. 22 
 6 
cepacia complex and related to B. ubonensis, may yet be a novel species within this 1 
taxonomic subgroup of Burkholderia. 2 
General features of the P. mesoacidophila ATCC 31433 genome. Annotation of the 3 
genome revealed numerous elements that suggest resilience to environmental conditions. 4 
Genes are present encoding detoxification proteins such as nitric oxide dioxygenase 5 
flavohaemoglobin, superoxide dismutase, catalase, catalase/peroxidase, thiol peroxidase, 6 
alkylhydroperoxidase and alkylhydroperoxide reductase, alkylsulfonate monooxygenase 7 
and transport proteins, and a range of proteins involved in sulfite metabolism, DNA 8 
repair and the osmotic stress response. Genes and gene clusters required for uptake and 9 
metabolism of chitin, collagen, pectin, lignin and other phenylpropanoids, phospholipids, 10 
glycerol, arabinose, ribose, fucose, xylose, trehalose, polyols, glycolate, lactate, 2-11 
ketogluconate, hydantoin, allantoin, haem, taurine, putrescine and methylamine were all 12 
identified. Siderophore synthetases, transport proteins and receptors are present, along 13 
with several other proteins involved in metal homeostasis. Genes encoding a wide range 14 
of antibiotic resistance proteins and efflux pumps are also present. 15 
Interactions with the environment are also mediated by the chaperone-usher type 16 
fimbriae, Flp pilus, type IV pilus, adhesins and biofilm-forming proteins (PgaABCD and 17 
PelABCDEFG) identified, while motility is suggested by genes encoding flagella 18 
components. Lipopolysaccharide biosynthesis genes include those for O-antigen 19 
biosynthesis and Lipid A modification. A number of genes and gene clusters involved in 20 
specialised metabolite biosynthesis were indicated. In addition, the genome contains 21 
several phage proteins, transposases, and Tra and Trb conjugative transfer proteins. 22 
 7 
P. mesoacidophila harbours genes encoding secreted enzymes and toxins involved in 1 
virulence and interaction with a host, such as phospholipases (including a 2 
phosphatidylinositol-specific phospholipase C seen in other Burkholderia species (15)), 3 
secreted collagenase, LasA protease, secreted zinc metalloprotease, pectin-degrading 4 
polygalacturonase, HigAB, RelBE, YgiTU and VapBC antitoxin/toxin pairs, RTX toxin, 5 
Phd antitoxin, and toxin secretion proteins. Components of possible Type I, II, III, IV and 6 
VI secretion systems have also been identified. 7 
Specialised metabolite production by P. mesoacidophila ATCC 31433. To uncover the 8 
secondary metabolite potential of P. mesoacidophila we analysed the genome using the 9 
antiSMASH tool (16), and performed comparative investigations on other B. ubonensis 10 
genomes. This identified 91 putative biosynthetic gene clusters from five isolates. P. 11 
mesoacidophila yielded 24 clusters, suggesting 40% more biosynthetic potential than the 12 
other B. ubonensis isolates analysed (Table 1).  13 
A small proportion of the biosynthetic clusters identified are required for the biosynthesis 14 
of known compounds. Of the nine PKS and NRPS clusters, three are known, three have 15 
equivalents in other Burkholderia species, and three have no established equivalents 16 
indicated by antiSMASH. The complete PKS cluster for malleilactone (17) production 17 
and the NRPS cluster for ornibactin (18) biosynthesis were found, and the NRPS part of 18 
the “ectoine-arylpolyene-NRPS” cluster is similar to the sulfazecin biosynthesis cluster in 19 
Pseudomonas acidophila (19), with the exception that the SulM equivalent in P. 20 
mesoacidophila has no epimerisation domain. This group of genes is therefore 21 
responsible for isosulfazecin biosynthesis. The complete four-gene cluster required for 22 
biosynthesis of the antifungal pyrrolnitrin (20) is present, although we could not detect 23 
 8 
production of this metabolite in either the culture broth or partially purified cell extracts 1 
by LC-MS. Genes necessary for alkylhydroxyquinoline synthesis, involved in quorum 2 
sensing (21), were found in one of the NRPS clusters. 3 
One of the three terpene clusters comprises part of the hopanoid biosynthetic pathway 4 
described in B. cenocepacia J2315 (encoding seven proteins with >75% identity to their 5 
counterparts HpnCEFGMN and VacJ, plus two proteins not found in that species) (15, 6 
22). A response regulator gene just downstream of the hpnCEFGMN cluster encodes a 7 
protein 84% identical to Bp1026b_II2523 from B. pseudomallei, which is involved in 8 
thermoregulation and biofilm formation (23). Clusters equivalent to hpnABH/ispH and 9 
hpnIJKL/ompA in B. cenocepacia J2315 (22) (>75% identical at the protein level) were 10 
also found, making up the entire hopanoid biosynthetic pathway. The other two terpene 11 
clusters and the “homoserine lactone-terpene” cluster contain one isolated squalene-12 
hopene cyclase and two isolated squalene synthase genes. The homoserine lactone 13 
synthase and its associated regulator found in the “homoserine lactone-terpene” cluster, 14 
involved in quorum sensing, encode proteins >85% identical to their equivalents in B. 15 
cenocepacia J2315 (15, 24).  16 
In addition to core genes encoding fatty acid synthase components >80% identical to 17 
those seen in other Burkholderia species (25), two genes encoding cyclopropane fatty 18 
acyl phospholipid synthases (known components of Burkholderia cell membranes (26)), 19 
and one encoding diffusible factor synthase (90% identical at the protein level to 20 
BCAM0581 from B. cenocepacia J2315), responsible for production of a fatty acid 21 
involved in quorum sensing (27), were found. P. mesoacidophila also produces poly(β-22 
 9 
hydroxybutanoate) (1), and poly(β-hydroxyalkanoate) synthase and depolymerase genes 1 
were identified.  2 
Production of bulgecin by P. mesoacidophila. We sought to confirm the presence of 3 
bulgecin in the culture broth of P. mesoacidophila ATCC 31433. Bulgecin has previously 4 
been shown to potentiate the activity of β-lactam antibiotics and to cause bulge formation 5 
in E. coli (2, 28). After 78 hr growing at 28 °C in PF medium P. mesoacidophila gave 36 6 
g cell pellet per litre of culture, and reduced the pH of the medium from 7.0 to 5.5 ± 0.5.  7 
The medium acquired a distinctive fruity smell and remained translucent even after 8 
repeated centrifuging at 6,000 g to remove cells. The culture filtrate of P. mesoacidophila 9 
potentiated the lytic activity of cefuroxime against E. coli and caused bulge formation 10 
(Figure 3), as expected if bulgecin were present (2, 28). E. coli JM109 cells exposed to a 11 
sub-lethal concentration of cefuroxime grew as long cell chains, consistent with this 12 
compound’s selective inhibition of PBP3 and prevention of proper septation (29), 13 
whereas those exposed to the same concentration of cefuroxime in P. mesoacidophila 14 
culture broth developed bulges at the sites of septation (2, 28).  15 
Antibiotic and metal resistance of P. mesoacidophila. P. mesoacidophila was resistant 16 
to a wide range of antibiotics (Table 2), including the antipseudomonal aminoglycoside 17 
tobramycin, the carbapenems, the monobactam aztreonam, and polymyxin B. Of the 24 18 
antibiotics tested, only the antipseudomonal β-lactams piperacillin and ceftazidime 19 
showed clear activity against P. mesoacidophila, with the fluoroquinolone ciprofloxacin 20 
and the fourth-generation cephalosporin cefepime showing intermediate activity. In a few 21 
cases the zone diameters in disc diffusion assays were close to the breakpoint value (with 22 
some replicates indicating resistance and others suggesting a degree of susceptibility), 23 
 10 
while the broth microdilution method clearly indicated resistance. Burkholderia species 1 
are known to give poor correlation between the two methods (30). E. coli JM109, tested 2 
simultaneously, was susceptible to all antibiotics assayed except erythromycin and 3 
nalidixic acid, as expected (data not shown). 4 
P. mesoacidophila has predicted genes for β-lactamases from classes A and C, along with 5 
other proteins containing β-lactamase domains. Inducible β-lactamase activity was 6 
demonstrated using cefoxitin (Table 4), whereas no inducible β-lactamase activity, and 7 
much greater susceptibility to cefoxitin, was seen for E. coli JM109. Two of the genes 8 
thought to encode class A β-lactamases have 63% and 54% identity with known 9 
inducible class A β-lactamases from Burkholderia mallei and B. pseudomallei (31).  10 
Resistance to polymyxin B is rare among Gram-negative species, including 11 
pseudomonads, but is well known in Burkholderia species, where the modification of 12 
Lipid A prevents antibiotic binding (32). Indeed, the Arn gene cluster, responsible for 13 
biosynthesis of 4-amino-4-deoxyarabinose and its incorporation into Lipid A, has been 14 
identified (33, 34). This outer membrane modification also confers decreased 15 
susceptibility to aminoglycosides, which, together with a predicted aminoglycoside 16 
phosphotransferase (also seen in B. cenocepacia strain J2315 (15)) and several membrane 17 
efflux pumps, accounts for the marked resistance to this class of antibiotics (35, 36).  18 
The genome also carries genes encoding CreBCD colicin resistance proteins, a bleomycin 19 
(glycopeptide) resistance protein (63% identical to the Tn5-mediated bleomycin 20 
resistance protein (37), including conservation of the bleomycin binding regions), and 21 
phosphinothricin N-acetyltransferase (36% identical to phosphinothricin N-22 
acetyltransferase from Brucella ovis (WP_006155257; PDB 5DWN), with significant 23 
 11 
conservation of the active site), various acyltransferases and glycosyltransferases that 1 
may play a role in resistance, and an undecaprenyl diphosphatase associated with 2 
bacitracin resistance (38). Genes potentially encoding putative trimethoprim resistant 3 
dihydrofolate reductase FolM (25% identity with FolM from E. coli) and 4 
chloramphenicol phosphotransferase (27% identical to the N-terminal two-thirds of the 5 
chloramphenicol phosphotransferase from Streptomyces venezualae (CCA57350 (39); 6 
PDB 5DWN), with the active site substantially conserved) were also found. 7 
Genes were identified encoding efflux pumps from the major facilitator superfamily 8 
(MFS); the ATP-binding cassette (ABC) family, including a putative MacAB (macrolide 9 
resistance) system; the resistance-nodulation-division (RND) family, including putative 10 
AcrAB (acriflavin resistance), CmeABC and NodT family pumps; the drug/metabolite 11 
transporter (DMT) family, including putative EmrE (ethidium bromide/methyl viologen 12 
resistance) proteins; the LysE family; and the multi-antimicrobial extrusion (MATE) 13 
family. Efflux pumps specifically annotated as bicyclomycin (peptide) resistance and 14 
fosmidomycin (phosphonate) resistance proteins are present. 15 
P. mesoacidophila was also resistant to metal ions (Table 3), with the order of resistance 16 
for the transition metals tested being Mn
2+
>Ni
2+
>Zn
2+
>Fe
3+≈Cu2+>Co2+>>Hg2+. E. coli 17 
JM109, in comparison, was sensitive to all transition metals tested, with MICs for MnCl2 18 
and HgCl2 of <4 M. Several predicted genes encoding heavy metal resistance proteins 19 
were found. These include arsenate reductase and other arsenic resistance proteins, 20 
chromate transporter ChrAB, cobalt/zinc/cadmium transporter CzcABCD (with a two-21 
component regulator similar to that mediating metal resistance in B. pseudomallei (40)), 22 
copper resistance proteins CopCD, HoxN/HupN/NixA family nickel/cobalt transporter, 23 
 12 
lead/cadmium/zinc/mercury transporter, manganese transport protein MntH, 1 
magnesium/cobalt efflux pump CorAC, and tellurium resistance proteins TerABCD. 2 
 3 
DISCUSSION 4 
The 7.8 MB genome of strain ATCC 31433 was sequenced and found to comprise three 5 
chromosomal replicons and one plasmid. MLST analysis reveals that strain ATCC 31433, 6 
rather than being a pseudomonad, is a member of the Burkholderia cepacia complex and 7 
closely related to B. ubonensis, although it may still be a distinct species. Further analysis 8 
of the bioactivity, taxonomy and genomics of strain ATCC 31433 is warranted under the 9 
reclassification as a member of the B. cepacia complex. 10 
Strain ATCC 31433 harbors many genes associated with environmental resilience and 11 
antibiotic resistance, including a wide range of efflux pumps. Antibiotic and metal 12 
susceptibility testing confirmed the resistant phenotype. Only two of the twenty-four 13 
antibiotics tested (piperacillin and ceftazidime) showed clear activity against strain 14 
ATCC 31433, and a similar resistance to transition metal ions was observed. While many 15 
of the predicted heavy metal resistance genes encode efflux pumps, other detoxification 16 
systems were also seen. Several environmental Burkholderia strains have been described 17 
as metal resistant, although most of these are in fact less tolerant of metal ions than P. 18 
mesoacidophila (40–43). The antibiotic resistance found in strain ATCC 31433 is similar 19 
to that seen in Burkholderia species. Indeed, several Burkholderia species have been 20 
identified with high-level β-lactam resistance (9, 44). Pseudomonads are generally 21 
susceptible to monobactams, carbapenems, cefepime, aminoglycosides and polymyxin B, 22 
whereas strain ATCC 31433 is resistant to all of these, including the antipseudomonal 23 
 13 
aminoglycoside tobramycin. Resistance to monobactams may also be explained by the 1 
production of isosulfazecin by strain ATCC 31433 (1). The biosynthetic gene cluster for 2 
this metabolite, like that of sulfazecin in P. acidophila (19), contains efflux pumps and a 3 
β-lactamase as self-resistance mechanisms.  4 
Despite the potential pathogenicity suggested by the genome sequence, to our knowledge 5 
there are no reported cases of strain ATCC 31433 causing disease; however, 6 
opportunistic pathogenicity towards vulnerable hosts remains an inherent trait of the B. 7 
cepacia complex (9). Conversely, the large number of biosynthetic gene clusters 8 
identified in the genome of strain ATCC 31433 suggest that it may be a rich source of 9 
secondary metabolites compared to related Burkholderia species, and B. ubonensis has 10 
been shown to have activity against the pathogen B. pseudomallei (45). AntiSMASH (16) 11 
analysis of the strain ATCC 31433 genome identified known gene clusters for 12 
malleilactone, ornibactin, isosulfazecin, alkylhydroxyquinoline and pyrrolnitrin 13 
biosynthesis, while revealing additional biosynthetic potential from uncharacterized 14 
biosynthetic gene clusters for PKS, NRPS and other metabolites. Genes encoding 15 
bacteriocins, thought to be the active principle in B. ubonensis against B. pseudomallei 16 
(45), were found. Biosynthesis of bulgecin is of particular interest. The biosynthetic route 17 
to the bulgecinine (4-hydroxy-5-hydroxymethylproline) core of bulgecin (12, 46) is 18 
unknown, but may involve direct elaboration of proline or the action of a transketolase on 19 
hydroxypyruvate and aspartate semialdehyde, prior to being transferred to NRPS, 20 
glycosyltransferase and sulfotransferase components to form bulgecin A itself. Several 21 
candidate genes have been identified for further investigation. 22 
 14 
In summary, the genome sequence of strain ATCC 31433 is consistent with an 1 
environmental Burkholderia isolate from within the B. cepacia complex. The full 2 
biosynthetic potential of this strain, including location of the gene cluster responsible for 3 
biosynthetic of the bulgecins and identification of the products of the uncharacterized 4 
gene clusters, as well as the precise classification of the strain, merit further investigation. 5 
Bulgecin may prove a valuable tool for studying and overcoming antibiotic resistance. 6 
 7 
MATERIALS AND METHODS 8 
Bacterial strains and susceptibility testing  9 
P. mesoacidophila ATCC 31433 was purchased from LGC Standards and grown at 28 ºC 10 
in PS broth (1% w/v glucose, 0.5% w/v tryptone, 0.5% w/v meat extract, 0.5% w/v NaCl, 11 
pH 7.0) except where indicated. Escherichia coli JM109 was purchased from Promega 12 
and grown at 37 ºC in LB medium except where indicated. Antibiotics and metal salts 13 
were from Sigma-Aldrich (Poole, U.K.) or Melford (Ipswich, U.K.). All antibiotic 14 
susceptibility testing followed the methods of BSAC (47), except that Mueller-Hinton II 15 
agar (Sigma-Aldrich, Poole, U.K.) was used for disc diffusion assays, and PS broth was 16 
used for broth microdilution assays. Breakpoints are taken from BSAC Susceptibility 17 
Testing Method version 14 (30). For disc diffusion assays, antibiotic discs (maximum 18 
three per plate) were prepared using 5 mm filter paper discs impregnated with 5 μL 19 
antibiotic stock. Metal susceptibility testing was only performed using broth 20 
microdilution assays, with 10, 1 or 0.001 mg mL
-1
 metal salt as the highest concentration 21 
on the plate. Antibiotic and metal susceptibility testing was performed at least in 22 
 15 
triplicate. Equivalent replicates for P. mesoacidophila and E. coli JM109 were performed 1 
on the same day using the same antibiotic stock.  2 
Genome analysis. Genomic DNA was prepared from a 3 mL overnight culture of P. 3 
mesoacidophila in tryptic soya broth (Thermo Fisher Scientific).  Cells were harvested by 4 
centrifugation and resuspended in 400 μL of 4 M guanidine isothiocyanate solution 5 
(Thermo Fisher Scientific).  DNA extraction was performed using the Maxwell
®
 16 6 
automated nucleic acid purification system with the Maxwell
®
 Tissue DNA purification 7 
kit, following the manufacturer’s instructions (Promega).   8 
The genome sequence was assembled from data obtained from two SMRT cells on a 9 
PacBio RSII sequencer using Canu 1.3 (48), polished with Quiver 2.1.0 from Pacific 10 
Biosciences (California, USA), and circularized where possible using Circlator 1.2.1 (49). 11 
Gene annotations were made using PROKKA 1.11 (50) and RAST (51–53). Biosynthetic 12 
gene clusters on the genome were analysed using AntiSMASH 3.0 (16). Graphical 13 
genome comparisons were obtained with EasyFig 2.2.2 and Average Nucleotide Identity 14 
(ANI) calculated with pyani 0.2.1. A virtual machine hosted by the Cloud Infrastructure 15 
for Microbial Bioinformatics (CLIMB) consortium (54) was used to perform genome 16 
assembly, annotation and comparisons. 17 
The sequences of six MLST alleles (trpB, recA, lepA, gyrB, gltB and atpD) from P. 18 
mesoacidophila and six available B. ubonensis genomes were concatenated and aligned.  19 
The corresponding loci from 26 Burkholderia species were downloaded from the 20 
Burkholderia MLST database at http://pubMLST.org.  A phylogeny was reconstructed 21 
with Geneious 7.1.9 Tree Builder using the Tamura-nei genetic distance model and 22 
neighbour joining tree build method.  23 
 16 
Detection of inducible β-lactamase activity. Starter cultures of P. mesoacidophila and E. 1 
coli JM109 were each sub-cultured (1:50 dilution) into four 100 mL portions of fresh PS 2 
broth and grown at 28 ºC. Once A600 ~0.4 was attained, cefoxitin was added to give final 3 
concentrations of 0, 1, 10 and 100 μg mL-1. Three hours after addition of cefoxitin, a 25 4 
mL aliquot was removed from each flask and cells lysed by sonication. The crude cellular 5 
lysate (100 μL) was then added to 200 μM nitrocefin solution in 50 mM sodium 6 
cacodylate buffer (pH 7.0) containing 100 μM ZnCl2 and 150 mM NaCl (900 μL), and 7 
the initial rate of hydrolysis recorded by monitoring the decrease in absorbance at 8 
482 nm. Three repeats were obtained for each initial rate of hydrolysis, and the entire 9 
experiment was performed in triplicate. 10 
Detection of bulgecin activity. A 48-hour culture of P. mesoacidophila in PS broth was 11 
sub-cultured (1:50 dilution) into PF broth (3% glycerol, 0.5% w/v tryptone, 0.5% w/v 12 
meat extract, 0.5% w/v NaCl, 0.1% w/v glucose and 0.1% w/v cysteine, pH 7.0), and 13 
incubated at 28 °C, 200 rpm for 78 hours. Cells were removed by centrifugation, and 14 
nutrients were replenished in the supernatant solution by addition of 0.8% w/v Nutrient 15 
Broth No. 3 (Sigma-Aldrich, Poole, U.K.) (i.e. 0.5% w/v tryptone and 0.3% w/v meat 16 
extract), 2% w/v glycerol and 0.1% w/v glucose. All broths were readjusted to pH 7 and 17 
held at 4 °C overnight. 18 
An overnight culture of E. coli JM109 in LB medium was sub-cultured (1:50 dilution) 19 
into fresh LB medium and grown at 37 °C, 250 rpm to A600 ~0.3.  Cultures were 20 
centrifuged and the cell pellets resuspended in the test broths. Cultures were then grown 21 
at 37 °C, 250 rpm for a further four hours.  Cefuroxime (final concentration 5 μg mL-1) 22 
was added to one of each pair of flasks after 30 minutes. 60 and 90 minutes after 23 
 17 
cefuroxime addition, aliquots were removed and cells were viewed by light microscopy 1 
using an Ultraphot microscope (Zeiss). These experiments were repeated four times.  2 
Accession numbers. The assembled genome sequence has been deposited at Genbank 3 
under accession numbers CP020737-CP020740.  The corresponding raw sequence read 4 
data are available from the European Nucleotide Archive under accession number 5 
ERP022292. 6 
 7 
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FIGURE LEGENDS 18 
Figure 1. Phylogeny of P. mesoacidophila ATCC 31433 within the genus 19 
Burkholderia. Analysis based on the sequences of six MLST alleles (trpB, recA, lepA, 20 
gyrB, gltB and atpD). The isolate ID is shown in brackets after each species. 21 
 22 
 18 
Figure 2. Genome sequence comparison of P. mesoacidophila ATCC 31433 and B. 1 
ubonensis MSMB1471. Each chromosome is displayed separately and to scale 2 
(indicated), with P. mesoacidophila ATCC 31433 above and B. ubonensis MSMB1471 3 
below. Regions of homologous sequence are linked with red lines. AntiSMASH predicted 4 
gene clusters are shown in purple. The smallest contig of the P. mesoacidophila ATCC 5 
31433 genome is not shown, as this had neither homology with B. ubonensis MSMB1471 6 
nor contained any antiSMASH predicted biosynthetic pathways. 7 
 8 
Figure 3. Cefuroxime potentiation and bulge-forming activity. Growth curves of E. 9 
coli JM109 in PS medium without (light blue) and with (dark blue) 5 μg mL-1 10 
cefuroxime, and in P. mesoacidophila culture filtrate without (orange) and with (red) 5 11 
μg mL-1 cefuroxime (a), and light microscopy of E. coli JM109 alone (b) and exposed to 12 
5 μg mL-1 cefuroxime (c), P. mesoacidophila culture filtrate (d) and a combination of 5 13 
μg mL-1 cefuroxime and P. mesoacidophila culture filtrate (e). Cefuroxime potentiation 14 
and bulge formation are consistent with the presence of bulgecin (2, 28). 15 
 16 
Table 1. Biosynthetic gene clusters from P. mesoacidophila and B. ubonensis. The 17 
number of secondary metabolite clusters predicted by antiSMASH in P. mesoacidophila 18 
and five closely related isolates of B. ubonensis is shown. 19 
*PKS-containing clusters include T1PKS, Transatpks, otherKS or any mixed cluster 20 
containing one of these types. 21 
 22 
 19 
Table 2: Antibiotic susceptibility of P. mesoacidophila ATCC 31433, determined by 1 
the broth microdilution and disc diffusion methods. *
 
nd: not determined. 
†
 2 
Breakpoints are for Pseudomonas spp. Breakpoints in brackets are for Enterobacteriacae. 3 
The “polymyxin B” breakpoint is for colistin (polymyxin E). ‡ R = resistant, I = 4 
intermediate, S = susceptible. 5 
 6 
Table 3: Metal ion susceptibility of P. mesoacidophila ATCC 31433, determined by 7 
the broth microdilution method. Note that all broths contained 5 mg mL
-1
 NaCl. 8 
 9 
Table 4: Induction of β-lactamase activity in P. mesoacidophila ATCC 31433 by 10 
cefoxitin. Growth of P. mesoacidophila ATCC 31433 was unaffected by cefoxitin at the 11 
concentrations used. 12 
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Figure 1. Phylogeny of P. mesoacidophila ATCC 31433 within the genus 2 
Burkholderia. Analysis based on the sequences of six MLST alleles (trpB, recA, lepA, 3 
gyrB, gltB and atpD). The isolate ID is shown in brackets after each species. 4 
 5 
6 
 29 
 1 
 2 
Figure 2. Genome sequence comparison of P. mesoacidophila ATCC 31433 and B. 3 
ubonensis MSMB1471. Each chromosome is displayed separately and to scale 4 
(indicated), with P. mesoacidophila ATCC 31433 above and B. ubonensis MSMB1471 5 
below. Regions of homologous sequence are linked with red lines. AntiSMASH predicted 6 
gene clusters are shown in purple. The smallest contig of the P. mesoacidophila ATCC 7 
31433 genome is not shown, as this had neither homology with B. ubonensis MSMB1471 8 
nor contained any antiSMASH predicted biosynthetic pathways. 9 
 10 
11 
 30 
 1 
Figure 3. Cefuroxime potentiation and bulge-forming activity. Growth curves of E. 2 
coli JM109 in PS medium without (light blue) and with (dark blue) 5 μg mL-1 3 
cefuroxime, and in P. mesoacidophila culture filtrate without (orange) and with (red) 5 4 
μg mL-1 cefuroxime (a), and light microscopy of E. coli JM109 alone (b) and exposed to 5 
5 μg mL-1 cefuroxime (c), P. mesoacidophila culture filtrate (d) and a combination of 5 6 
μg mL-1 cefuroxime and P. mesoacidophila culture filtrate (e). Cefuroxime potentiation 7 
and bulge formation are consistent with the presence of bulgecin (2, 28). 8 
 9 
10 
 31 
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B. ubonensis RF23-BP41 3 2 3 1 1 3 0 0 1 1 1 0 1 17 
B. ubonensis SMB1471WGS 2 3 3 1 0 4 0 0 1 1 0 0 2 18 
B. ubonensis MSMB2035  3 1 3 1 0 2 0 0 1 1 1 0 1 14 
B. ubonensis BCC 1603 4 2 3 1 0 3 0 0 1 1 1 0 2 18 
P. mesoacidophila ATCC 
31433 
5 3 3 3 0 2 1 1 1 1 1 1 2 24 
                            91 
Table 1. Biosynthetic gene clusters from P. mesoacidophila and B. ubonensis. The 2 
number of secondary metabolite clusters predicted by antiSMASH in P. mesoacidophila 3 
and five closely related isolates of B. ubonensis is shown. 4 
*PKS-containing clusters include T1PKS, Transatpks, otherKS or any mixed cluster 5 
containing one of these types. 6 
 7 
8 
 32 
 1 
Antibiotic 
Microdilution method Disc diffusion method 
Resistant?
‡
 MIC* / 
µg mL
-1 
Breakpoints
†
 Dose 
/ µg 
Zone of 
inhibition 
/ mm 
Breakpoints
†
 
R > S ≤ R ≤ S ≥ 
Amoxicillin >128 (8) (8) 30 0 (14) (15) R 
Co-amoxiclav >128 (8) (8) 20/10 0 (20) (21) R 
Ampicillin nd   25 0 (14) (15) R 
Carbenicillin >128   100 12 12 13 R 
Piperacillin 8 16 16 75 37 24 25 S 
Cefuroxime >128 (8) (8) 30 21 (19) (20) R 
Cefoxitin >128 (8) (8) 30 8 (22) (23) R 
Cefotaxime 16 (2) (1) 30 23 26 27 R 
Ceftazidime 8 8 8 30 29 23 24 S 
Cefepime 4 (4) (1) 30 31 (26) (30) I 
Imipenem nd 8 4 10 12 16 23 R 
Meropenem 16 8 2 10 19 15 20 R 
Aztreonam 128 16 1 30 18 19 36 R 
Erythromycin >128   30 0   R 
Tetracycline 64   10 0 (23) (24) R 
Chloramphenicol 32 (8) (8) 30 17 (20) (21) R 
Streptomycin nd   10 0   R 
Kanamycin 64   30 18   R 
Gentamicin 128 4 4 10 9 17 18 R 
Tobramycin nd 4 4 10 11 19 20 R 
Nalidixic acid 32 (16) (16) 30 20 (17) (18) R 
Ciprofloxacin 0.5 1 0.5 5 26 19 30 I 
Rifampicin 16   30 18    
Polymyxin B 64 4 4 25 14   R 
 
2 
Table 2: Antibiotic susceptibility of P. mesoacidophila ATCC 31433, determined by 3 
the broth microdilution and disc diffusion methods. *
 
nd: not determined. 
†
 4 
Breakpoints are for Pseudomonas spp. Breakpoints in brackets are for Enterobacteriacae. 5 
The “polymyxin B” breakpoint is for colistin (polymyxin E). ‡ R = resistant, I = 6 
intermediate, S = susceptible.
 
7 
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 33 
 1 
Salt 
MIC / 
mg mL
-
1 
MIC / 
mM 
NaCl
 
>15 >257 
KCl >10 >133 
MgCl2 >10 >105 
CaCl2 >10 >90 
MnCl2.4H2O 5 25 
FeCl3 1 6 
CoCl2.6H2O 0.25 1 
NiCl2 1.25 10 
CuCl2.2H2O 1 6 
ZnCl2 1 7 
HgCl2 0.008 0.03 
Table 3: Metal ion susceptibility of P. mesoacidophila ATCC 31433, determined by 2 
the broth microdilution method. Note that all broths contained 5 mg mL
-1
 NaCl. 3 
 4 
 5 
 6 
 7 
[Cefoxitin] / 
µg mL
-1 
Nitrocefin 
hydrolysis 
rate / nM s
-1 
-fold 
induction 
0 22.7 ± 3.4 1 
1 28.7 ± 1.4 1.3 ± 0.2 
10 68.5 ± 1.2 3.0 ± 0.5 
100 300.8 ± 29.9 13.2 ± 2.4 
Table 4: Induction of β-lactamase activity in P. mesoacidophila ATCC 31433 by 8 
cefoxitin. Growth of P. mesoacidophila ATCC 31433 was unaffected by cefoxitin at the 9 
concentrations used. 10 
 11 
